Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
Global infection control (disinfection & sterilization) market was valued at USD 17,820 million in 2024. The market is projected to grow to USD 24,600 million by 2031, exhibiting a CAGR of 4.8% during the forecast period. While North America currently dominates market share, Asia-Pacific is emerging as the fastest-growing region due to healthcare infrastructure development.
Infection control comprises disinfection and sterilization technologies crucial for preventing healthcare-associated infections (HAIs). These processes eliminate or reduce pathogenic microorganisms through physical, chemical, or physiochemical methods. The segment includes surface disinfectants, sterilization equipment (steam, ethylene oxide, hydrogen peroxide), and consumables like indicators and cleaning agents. Such products are vital for hospitals, pharmaceutical manufacturing, and research laboratories where contamination control is paramount.
The market growth is driven by increasing surgical volumes, stricter regulatory standards like FDA's 2023 guidance on ethylene oxide sterilization, and rising awareness of antimicrobial resistance. However, environmental concerns over chemical disinfectants present challenges. Key players like 3M, Steris, and Getinge are innovating eco-friendly solutions, as seen in 2024 product launches for low-temperature sterilization systems. The post-pandemic emphasis on hospital hygiene continues to sustain demand, particularly for automated disinfection systems.
Increasing Healthcare-Associated Infections (HAIs)
The global infection control market is experiencing growth due to rising cases of healthcare-associated infections (HAIs), with approximately 7% of hospitalized patients in developed nations and 15% in developing countries acquiring at least one HAI during their stay. Hospitals are increasing investments in sterilization and disinfection equipment to reduce infection rates.
Surgical Procedure Volumes Rising
With over 310 million major surgeries performed annually worldwide, the demand for effective sterilization of surgical instruments has never been higher. Regulatory bodies are enforcing stricter protocols for instrument processing, driving market growth for advanced sterilization technologies.
The global endoscope reprocessing market alone is projected to reach $3.2 billion by 2026 due to stringent reprocessing requirements
Outbreak preparedness following COVID-19 has led to permanent changes in hospital disinfection protocols, with many facilities maintaining enhanced cleaning regimens even as pandemic pressures subside.
MARKET CHALLENGES
High Equipment and Operational Costs
Advanced sterilization systems like hydrogen peroxide vapor units can exceed $100,000 per unit, with significant ongoing costs for consumables and maintenance. Smaller healthcare facilities often struggle to justify these investments despite clear infection prevention benefits.
Other Challenges
Staff Training Requirements
Proper operation of sterilization equipment requires specialized training that contributes to personnel costs. Turnover in sterile processing departments creates constant retraining needs.
Regulatory Compliance Burden
Meeting evolving standards from FDA, EMA, and other agencies requires continuous process updates and documentation, particularly for ethylene oxide sterilization alternatives.
Environmental Concerns Over Chemical Disinfectants
Growing restrictions on chemical disinfectants like glutaraldehyde and formaldehyde are limiting options for high-level disinfection. The EU's Biocidal Products Regulation has removed several traditional disinfectants from the market, forcing expensive reformulations.
Emerging Economies Investing in Healthcare Infrastructure
Countries like India and China are building hundreds of new hospitals annually, with sterilization infrastructure being prioritized. These markets show 12-15% annual growth rates for infection control products compared to 5-7% in developed markets.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Sterilization has emerged as the critical process for medical device manufacturers and healthcare facilities requiring absolute pathogen elimination. While disinfection solutions maintain strong demand for surface cleaning applications, sterilization technologies are seeing accelerated adoption due to increasingly stringent hospital-acquired infection prevention protocols and expanding surgical volumes globally. |
| By Application |
|
Hospitals dominate as the primary application environment, driven by critical needs for surgical instrument sterilization and environmental surface disinfection. The pharmaceuticals segment shows strong growth potential with increasing emphasis on aseptic manufacturing processes. Biotechnology applications are gaining momentum with specialized sterilization requirements for bioprocessing equipment and containment facilities. |
| By End User |
|
Healthcare Facilities represent the most demanding end-users with constant throughput of reusable medical devices requiring validated sterilization cycles. Medical device manufacturers show particular preference for ethylene oxide sterilization methods compatible with sensitive components. Research institutions demonstrate growing adoption of specialized disinfection protocols for laboratory biosafety requirements. |
| By Technology |
|
Chemical Sterilization methods including ethylene oxide and hydrogen peroxide plasma maintain dominant positions due to material compatibility advantages. Heat sterilization remains essential for moisture-stable instruments through steam autoclaving, while radiation technologies find increasing application in single-use device manufacturing and terminal sterilization processes. |
| By Service Provider |
|
Contract Sterilization services are experiencing accelerated adoption as healthcare systems outsource complex sterilization needs to specialized providers. While major hospitals maintain core in-house capabilities, contract services offer economic advantages for low-volume users and specialized applications. Third-party validation services are becoming increasingly critical for compliance with evolving regulatory standards across all segments. |
Global Infection Control Market Dominated by Multinational Giants and Specialized Providers
The global infection control market is led by multinational corporations such as 3M, Steris, and Getinge, which hold significant market share through comprehensive product portfolios covering both disinfection and sterilization segments. These major players benefit from extensive global distribution networks, strong R&D capabilities, and established brand recognition in healthcare settings. The market structure remains moderately concentrated, with the top five players accounting for substantial revenue share through innovative technologies and strategic acquisitions.
Niche segments are served by specialized providers like Advanced Sterilization Products (ASP) focusing on high-level disinfection systems and Sterigenics providing contract sterilization services. Regional players and emerging market competitors are gaining traction through cost-effective solutions, particularly in Asia-Pacific markets. The competitive landscape continues evolving with increasing emphasis on eco-friendly disinfection methods and automated sterilization solutions for healthcare facilities.
List of Key Infection Control Companies Profiled3M Company
Getinge AB
Ansell Limited
Belimed AG
Cantel Medical Corp
Sterigenics International
Halyard Health
Matachana Group
Miele Professional
Sotera Health
Reckitt Benckiser
The global infection control market is projected to grow from $17.8 billion in 2024 to $24.6 billion by 2031, driven by increasing healthcare-acquired infection concerns and stricter sterilization regulations. North America currently dominates market share, while Asia-Pacific shows the highest growth potential due to healthcare infrastructure development.
Other TrendsDisinfection Segment Expansion
Disinfection products account for the largest market share and are growing faster than sterilization methods, particularly in outpatient settings. This trend reflects shorter procedure times and the need for cost-effective solutions in developing economies.
Hospital Applications Drive DemandHospitals represent over 40% of the end-user market, with surgical instrument sterilization being the primary application. The COVID-19 pandemic has permanently increased demand for terminal disinfection technologies and single-use sterile packaging solutions. Major players like 3M and Steris continue to dominate through continuous product innovation in this space.
Emerging Technologies in Sterilization
Low-temperature sterilization methods are gaining traction, particularly for sensitive medical devices. Hydrogen peroxide plasma and vaporized hydrogen peroxide systems are replacing traditional ethylene oxide methods due to environmental and safety concerns. Automated endoscope reprocessors represent one of the fastest-growing equipment segments.
Regulatory Changes Impact MarketStricter FDA and EU MDR regulations for medical device reprocessing are compelling healthcare facilities to upgrade their infection control systems. This has created opportunities for companies offering compliant validation services and documentation solutions alongside their core disinfection products.
Regional Analysis: Infection Control (Disinfection & Sterilization) MarketEurope
Europe maintains strong infection control standards through centralized EU regulations and national healthcare policies emphasizing sterilization quality. The region shows increasing adoption of automated endoscope reprocessors and standardized disinfection protocols. Germany and France lead in hospital sterilization technology implementation, while Nordic countries focus on environmentally sustainable methods. Recent EU MDR regulations have intensified requirements for medical device reprocessing, creating opportunities for advanced disinfection system providers. The aging healthcare infrastructure in Eastern Europe presents growth potential for modernization of sterilization facilities.
Asia-Pacific
Asia-Pacific emerges as the fastest-growing region, driven by expanding healthcare systems and increasing surgical procedure volumes. Japan leads in automated sterilization technology adoption, while China focuses on upgrading central sterile supply departments in public hospitals. India shows rapid growth in private hospital chains implementing international-standard infection control protocols. The region benefits from cost-effective manufacturing of disinfection consumables, though regulatory harmonization remains a challenge across diverse markets. Southeast Asian countries emphasize sterilization training programs to improve healthcare-associated infection prevention.
Latin America
Latin America experiences moderate growth with Brazil and Mexico as key markets for hospital sterilization equipment. Limited reimbursement policies and economic constraints affect technology adoption rates, though increasing medical tourism drives higher standards in private hospitals. Government initiatives to reduce surgical site infections create demand for basic sterilization systems in public healthcare facilities. The region shows preference for cost-effective disinfection methods while gradually adopting advanced technologies in leading private institutions.
Middle East & Africa
The Middle East demonstrates strong growth potential with hospital construction projects incorporating modern sterilization facilities. Gulf countries implement stringent infection control regulations aligning with international standards. South Africa serves as the most advanced market in Sub-Saharan Africa, though limited healthcare budgets constrain technology adoption across most African nations. The region shows increasing interest in mobile sterilization units and outbreak-responsive disinfection solutions to address infectious disease challenges.
This market research report offers a holistic overview of global and regional markets for the forecast period 20252032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical and biotech companies
Healthcare providers and hospital systems
Medical device manufacturers
Research laboratories and institutions
Investors, consultants, and policy makers
-> Global infection control market was valued at USD 17,820 million in 2024 and is projected to reach USD 24,600 million by 2031.
Which key companies operate in Global Infection Control Market?
-> Key players include 3M, Advanced Sterilization, Ansell, Belimed, Cantel, Getinge, Halyard, Hartmann, Sterigenics, and Steris.
-> Key growth drivers include increasing surgical volumes, stricter regulatory standards, and rising awareness of antimicrobial resistance.
-> North America currently dominates market share, while Asia-Pacific is emerging as the fastest-growing region.
-> Emerging trends include low-temperature sterilization systems, automated disinfection solutions, and eco-friendly products.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates